[go: up one dir, main page]

AR009365A1 - Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno - Google Patents

Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno

Info

Publication number
AR009365A1
AR009365A1 ARP970104298A ARP970104298A AR009365A1 AR 009365 A1 AR009365 A1 AR 009365A1 AR P970104298 A ARP970104298 A AR P970104298A AR P970104298 A ARP970104298 A AR P970104298A AR 009365 A1 AR009365 A1 AR 009365A1
Authority
AR
Argentina
Prior art keywords
peptides
dna sequences
detection systems
fmdc
fmdv
Prior art date
Application number
ARP970104298A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR009365A1 publication Critical patent/AR009365A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Vacunas contra el virus de la glospeda a base de péptidos inmunogenos con una secuencia de al menos 8 aminoácidos, que corresponde a una secuenciaparcial procedente de la zona proteínica no estructural del virus de la glosopeda, que se has eleccionado por medio de inmuno-reactividad conanticuerposespecíficos del virus de la glosopeda o por medio de inmuno- reactividad con linfocitos T específicos del virus de la glosopeda así como alas proteínas, secuencias de ADN y a suempleo en sistemas de deteccion.
ARP970104298A 1996-09-18 1997-09-18 Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno AR009365A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19638044A DE19638044A1 (de) 1996-09-18 1996-09-18 Immunogene Peptide von Maul- und Klauenseuchen-Viren

Publications (1)

Publication Number Publication Date
AR009365A1 true AR009365A1 (es) 2000-04-12

Family

ID=7806008

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104298A AR009365A1 (es) 1996-09-18 1997-09-18 Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno

Country Status (13)

Country Link
US (2) US6984387B1 (es)
EP (1) EP0927256A1 (es)
CN (1) CN1122108C (es)
AR (1) AR009365A1 (es)
AU (1) AU723901B2 (es)
BR (1) BR9712067A (es)
CA (1) CA2265518A1 (es)
DE (1) DE19638044A1 (es)
HU (1) HUP9904171A3 (es)
IL (1) IL128847A0 (es)
RU (1) RU2202613C2 (es)
WO (1) WO1998012333A1 (es)
ZA (1) ZA978351B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810888B1 (fr) * 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
EP3066923B1 (en) 2006-01-30 2025-11-05 Panion & BF Biotech Inc. Method of treating chronic kidney disease
US7715679B2 (en) 2007-05-07 2010-05-11 Adc Telecommunications, Inc. Fiber optic enclosure with external cable spool
US8722079B2 (en) * 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
RU2453557C1 (ru) * 2010-11-03 2012-06-20 Алексей Сергеевич Фолимонов Состав полиэпитопного белка для индукции иммунного ответа против вируса ящура
RU2467014C2 (ru) * 2010-12-06 2012-11-20 Учреждение Российской академии наук Центр "Боинженерия" РАН Полиэпитопный белок, нуклеотидная последовательность, кодирующая полиэпитопный белок, плазмида с последовательностью, кодирующей полиэпитопный белок, и препарат полиэпитопного белка для индукции иммунного ответа против вируса ящура
CN102998460B (zh) * 2012-10-31 2014-12-10 广东海大畜牧兽医研究院有限公司 一种口蹄疫病毒抗体的elisa试剂盒及其制备方法
CN107513101B (zh) * 2017-09-18 2021-04-13 中牧实业股份有限公司 猪口蹄疫病毒非结构蛋白抗体酶联免疫检测试剂盒
CN111744000B (zh) * 2020-07-14 2021-03-23 中国农业科学院兰州兽医研究所 免疫抑制功能降低的口蹄疫重组病毒及其制备方法与应用
CN117304277B (zh) * 2023-09-26 2024-03-08 中国农业科学院兰州兽医研究所 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140763A (en) * 1976-09-08 1979-02-20 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for foot and mouth disease
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
HU210966B (en) * 1988-03-25 1995-09-28 Mallinckrodt Veterinary Inc Method for the preparation of peptides and veterinary compositions containing them
US5256641A (en) * 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
RU2043363C1 (ru) * 1992-04-28 1995-09-10 Институт биоорганической химии им.М.М.Шемякина РАН Пептид, обладающий защитным действием против ящура штамма a22
JP2813768B2 (ja) * 1995-05-24 1998-10-22 農林水産省家畜衛生試験場長 口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
US6048538A (en) 1997-10-03 2000-04-11 United Biomedical, Inc. Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents

Also Published As

Publication number Publication date
IL128847A0 (en) 2000-01-31
US20050058656A1 (en) 2005-03-17
HUP9904171A3 (en) 2001-10-29
BR9712067A (pt) 1999-08-24
ZA978351B (en) 1998-03-24
AU723901B2 (en) 2000-09-07
CA2265518A1 (en) 1998-03-26
AU4553697A (en) 1998-04-14
HK1024262A1 (en) 2000-10-05
RU2202613C2 (ru) 2003-04-20
CN1122108C (zh) 2003-09-24
CN1238011A (zh) 1999-12-08
WO1998012333A1 (de) 1998-03-26
US6984387B1 (en) 2006-01-10
HUP9904171A2 (hu) 2000-04-28
EP0927256A1 (de) 1999-07-07
DE19638044A1 (de) 1998-03-19

Similar Documents

Publication Publication Date Title
EA200100425A1 (ru) Новые способы терапевтической вакцинации
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
PT1090033E (pt) Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
ES2029171A6 (es) Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh)
DK0489968T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
ES2141081T3 (es) Nuevo aislado de hcv j-1.
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
SE9903031D0 (sv) Peptide mixture and vaccine against a chronic viral infection
RU99108121A (ru) Иммуногенные пептиды вирусов ящура
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
BR0112020A (pt) Partìculas tipo vìrus de bvdv
AR004567A1 (es) Metodos para detectar la infeccion de t.cruzi, en una muestra biologica, un vector de expresion recombinante, un microorganismo modificado, un kit de diagnostico, una composicion farmaceutica, el uso de la composicion farmaceutica para la preparacion de un medicamento para estimular la produccion de anticuerpos que se liguen a t. cruzi.
FR2724385B1 (fr) Vaccin de la peritonite infectieuse feline.
RU94040393A (ru) Синтетические пептиды для вакцины против краснухи
ATE208421T1 (de) Stimulierung der immunantwort durch virales protein
ATE374622T1 (de) Genetische impstoffe mit adjuvans
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
DK204588A (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider
SE8700466D0 (sv) Vaccines against melanoma
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
ATE143373T1 (de) Proteine, vakzine und nucleinsäuren
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis
AR003968A1 (es) Peptidos del virus de la arteritis equina, anticuerpos, una composicion para una vacuna, adn y arn recombinante, un plasmido, una celula, antisueros yanticuerpos, un metodo para analizar la presencia o cantidad de anticuerpos y del virus, y un equipo de ensayo
KR950005322A (ko) 소의 소형 피로플라즈마 병원충 감염의 예방용 펩티드

Legal Events

Date Code Title Description
FB Suspension of granting procedure